By cleaving mainly low-molecular-weight kininogen to release bradykinin, KLK1 promotes vasodilation, whereby an imbalance of the KKS and the renin–angiotensin system (RAS) causes hypertension, in addition to improving microcirculatory perfusion and modulating inflammation [117]. This evidence concerns the gene KLK1 and Hypertension.